Background: There is an urgent need to discover alternative antimicrobial agents to control bacterial wilt. The objectives of this study were to report a new lipopeptide-producing biocontrol strain FJAT-46737 and its lipopeptides, and to investigate their antagonistic effects.
Results: Based on the whole genome sequence analysis, the new strain FJAT-46737 was finally identified as Bacillus velezensis and seven gene clusters that responsible for synthesis of bioactive secondary metabolite in the FJAT-46737 were predicted. Antimicrobial results demonstrated that FJAT-46737 exhibited broad-spectrum antimicrobial activities in vitro against bacteria and fungi . The pot experiments showed that the tomato bacterial wilt control efficiencies of the whole cultures, the 2-fold diluted supernatants and the crude lipopeptide of FJAT-46737 were 66.2%, 82.0%, and 96.2%, respectively. The above results suggested that one of the antagonistic mechanisms of FJAT-46737 was secretion of lipopeptides that consisted of iturins, fengycins and surfactins. The crude lipopeptides had significant antagonistic activities on several pathogen in a dosage-dependent manner, and the fengycins confirmed to play a major role in antibacterial abilities in vitro of the lipopeptides against Ralstonia solanacearum . Furthermore, it was found that the rich organic nitrogen sources (especially yeast extracts) in the media were beneficial for FJAT-46737 to produce fengycin and surfactin. The secretion of these two lipopeptides were also adjusted by the culture temperature: the content of the fengycins decreased by 96.6% and that of the surfactins ascended by 59.9% from 20 o C to 40 o C. The temperature of 20 o C~25 o C is the suitable temperature for FJAT-46737 to produce lipopeptide.
Conclusions: The B. velezensis strain FJAT-46737 and its lipopeptides would used as new sources of potential biocontrol agents against plant pathogens, especially the bacterial wilt pathogen R. solanacearum .
Figure 1
Figure 2
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
On 15 Jun, 2020
On 15 Jun, 2020
Received 17 May, 2020
On 14 May, 2020
Invitations sent on 12 May, 2020
On 12 May, 2020
On 11 May, 2020
On 10 May, 2020
On 10 Nov, 2019
On 03 May, 2020
Received 02 May, 2020
Received 28 Apr, 2020
On 10 Apr, 2020
On 09 Apr, 2020
Invitations sent on 07 Apr, 2020
On 06 Apr, 2020
On 05 Apr, 2020
On 05 Apr, 2020
On 28 Mar, 2020
Received 20 Feb, 2020
Received 20 Feb, 2020
On 08 Feb, 2020
On 07 Feb, 2020
Invitations sent on 06 Feb, 2020
On 05 Feb, 2020
On 04 Feb, 2020
On 04 Feb, 2020
Posted 19 Dec, 2019
Received 20 Jan, 2020
On 20 Jan, 2020
Received 07 Jan, 2020
On 06 Jan, 2020
On 24 Dec, 2019
Invitations sent on 21 Dec, 2019
On 18 Dec, 2019
On 17 Dec, 2019
On 17 Dec, 2019
On 01 Dec, 2019
Received 22 Nov, 2019
Received 22 Nov, 2019
On 14 Nov, 2019
On 12 Nov, 2019
On 11 Nov, 2019
Invitations sent on 11 Nov, 2019
On 11 Nov, 2019
On 10 Nov, 2019
On 10 Nov, 2019
On 15 Jun, 2020
On 15 Jun, 2020
Received 17 May, 2020
On 14 May, 2020
Invitations sent on 12 May, 2020
On 12 May, 2020
On 11 May, 2020
On 10 May, 2020
On 10 Nov, 2019
On 03 May, 2020
Received 02 May, 2020
Received 28 Apr, 2020
On 10 Apr, 2020
On 09 Apr, 2020
Invitations sent on 07 Apr, 2020
On 06 Apr, 2020
On 05 Apr, 2020
On 05 Apr, 2020
On 28 Mar, 2020
Received 20 Feb, 2020
Received 20 Feb, 2020
On 08 Feb, 2020
On 07 Feb, 2020
Invitations sent on 06 Feb, 2020
On 05 Feb, 2020
On 04 Feb, 2020
On 04 Feb, 2020
Posted 19 Dec, 2019
Received 20 Jan, 2020
On 20 Jan, 2020
Received 07 Jan, 2020
On 06 Jan, 2020
On 24 Dec, 2019
Invitations sent on 21 Dec, 2019
On 18 Dec, 2019
On 17 Dec, 2019
On 17 Dec, 2019
On 01 Dec, 2019
Received 22 Nov, 2019
Received 22 Nov, 2019
On 14 Nov, 2019
On 12 Nov, 2019
On 11 Nov, 2019
Invitations sent on 11 Nov, 2019
On 11 Nov, 2019
On 10 Nov, 2019
On 10 Nov, 2019
Background: There is an urgent need to discover alternative antimicrobial agents to control bacterial wilt. The objectives of this study were to report a new lipopeptide-producing biocontrol strain FJAT-46737 and its lipopeptides, and to investigate their antagonistic effects.
Results: Based on the whole genome sequence analysis, the new strain FJAT-46737 was finally identified as Bacillus velezensis and seven gene clusters that responsible for synthesis of bioactive secondary metabolite in the FJAT-46737 were predicted. Antimicrobial results demonstrated that FJAT-46737 exhibited broad-spectrum antimicrobial activities in vitro against bacteria and fungi . The pot experiments showed that the tomato bacterial wilt control efficiencies of the whole cultures, the 2-fold diluted supernatants and the crude lipopeptide of FJAT-46737 were 66.2%, 82.0%, and 96.2%, respectively. The above results suggested that one of the antagonistic mechanisms of FJAT-46737 was secretion of lipopeptides that consisted of iturins, fengycins and surfactins. The crude lipopeptides had significant antagonistic activities on several pathogen in a dosage-dependent manner, and the fengycins confirmed to play a major role in antibacterial abilities in vitro of the lipopeptides against Ralstonia solanacearum . Furthermore, it was found that the rich organic nitrogen sources (especially yeast extracts) in the media were beneficial for FJAT-46737 to produce fengycin and surfactin. The secretion of these two lipopeptides were also adjusted by the culture temperature: the content of the fengycins decreased by 96.6% and that of the surfactins ascended by 59.9% from 20 o C to 40 o C. The temperature of 20 o C~25 o C is the suitable temperature for FJAT-46737 to produce lipopeptide.
Conclusions: The B. velezensis strain FJAT-46737 and its lipopeptides would used as new sources of potential biocontrol agents against plant pathogens, especially the bacterial wilt pathogen R. solanacearum .
Figure 1
Figure 2
Loading...